knowledge -WSS

knowledge

author：fashion 2025-10-01 15:29:14 - browse：5

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

explore

WSS

Judge rejects Trump's counterclaim against E. Jean Carroll

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Travel bans should be based on evidence, not politics or fear

Biden praises World Series champion Astros for impact off the field during White House celebration

Questions loom on AstraZeneca cancer drug as safety concerns ebb

UnitedHealth, Optum discontinue NaviHealth name

focus

knowledge

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Smaller biotechs seek to piggyback on weight loss drug boom

United colonoscopy coverage change 'may cost lives,' doctors say

ADCs take center stage as promising cancer treatments

In age of alternative facts, a scholarly course on calling out crap

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Apple is now the first public company to be valued at $3 trillion

STAT Readout: Friday, Oct. 20 biotech updates

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Cassava Sciences’ Alzheimer’s clinical trials should be halted

hotspot

Germany receives 178 compensation applications from gay servicepeople over discrimination

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Is there really a nursing shortage in the U.S.?

Roivant's CEO is a star, but biotech's black hole persists

FTX founder Sam Bankman

In venture capital firm's success, lessons for turning crisis into profit

explore

explore

focus

focus